Patents by Inventor Nissim Ben-Arie

Nissim Ben-Arie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
    Patent number: 7470673
    Abstract: Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also, an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated gene.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: December 30, 2008
    Assignee: Baylor College of Medicine
    Inventors: Huda Y. Zoghbi, Hugo Bellen, Nessan Bermingham, Bassem Hassan, Nissim Ben-arie
  • Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
    Patent number: 7442688
    Abstract: Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also, an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated gene.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: October 28, 2008
    Assignee: Baylor College of Medicine
    Inventors: Huda Y. Zoghbi, Hugo Bellen, Nessan Bermingham, Bassem Hassan, Nissim Ben-arie
  • Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
    Patent number: 7053200
    Abstract: Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also, an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated gene.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: May 30, 2006
    Assignee: Baylor College of Medicine
    Inventors: Huda Y. Zoghbi, Hugo Bellen, Nessan Bermingham, Bassem Hassan, Nissim Ben-arie
  • Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
    Patent number: 6838444
    Abstract: Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also, an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated gene.
    Type: Grant
    Filed: June 1, 2000
    Date of Patent: January 4, 2005
    Assignee: Baylor College of Medicine
    Inventors: Huda Y. Zoghbi, Hugo J. Bellen, Nessan A. Bermingham, Bassem Hassan, Nissim Ben-Arie
  • Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
    Publication number: 20040237127
    Abstract: Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also, an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated gene.
    Type: Application
    Filed: June 3, 2004
    Publication date: November 25, 2004
    Inventors: Huda Y. Zoghbi, Hugo J. Bellen, Nessan A. Bermingham, Bassem Hassan, Nissim Ben-Arie
  • Composition and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis and abnormal cell proliferation
    Publication number: 20040231009
    Abstract: Compositions and methods are disclosed for the therapeutic use of an atonal-associated nucleic acid or amino acid sequence. Also, an animal heterozygous for an atonal-associated gene inactivation is also disclosed having at least one atonal-associated nucleic acid sequence replaced by insertion of a heterologous nucleic acid sequence used to detect expression driven by an atonal-associated promoter sequence, wherein the inactivation of the atonal-associated nucleic acid sequence prevents expression of the atonal-associated gene.
    Type: Application
    Filed: June 3, 2004
    Publication date: November 18, 2004
    Inventors: Huda Y. Zoghbi, Hugo J. Bellen, Nessan A. Bermingham, Bassem Hassan, Nissim Ben-Arie